Spectral AI Inc(MDAI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 7:35 PM ET (Korea 11/4 09:35)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.35 | Insider Own | 16.24% | Shs Outstand | 32.2M | Perf Week | -1.96% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 33.57% | Insider Trans | - | Shs Float | 27.0M | Perf Month | -11.24% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.14 | Inst Own | 12.06% | Short Float | 8.03% | Perf Quarter | -7.98% |
| Income | -0.01B | P/S | 3.18 | EPS this Y | -60.92% | Inst Trans | 8.32% | Short Ratio | 15.57 | Perf Half Y | -33.92% |
| Sales | 0.02B | P/B | - | EPS next 5Y | - | ROA | -59.24% | Short Interest | 2.16M | Perf YTD | 5.63% |
| Book/sh | -0.37 | P/C | 3.45 | EPS past 3/5Y | -8.8% - | ROE | - | 52W High | -49.49% ($2.97) | Perf Year | -24.24% |
| Cash/sh | 0.43 | P/FCF | - | Sales past 3/5Y | -8.16% - | ROIC | - | 52W Low | 27.12% ($1.18) | Perf 3Y | -50.66% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 48.57% | Gross Margin | 41.51% | Volatility(W/M) | 4.66% 4.2% | Perf 5Y | -84.62% |
| Dividend TTM | - | EV/Sales | 3.33 | Sales Y/Y TTM | -44.99% | Oper. Margin | -79.95% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.85 | EPS Q/Q | 58.46% | Profit Margin | -69.27% | RSI (14) | 41.83 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.9 | Sales Q/Q | -30.42% | SMA20 | -2.79% ($1.54) | Beta | 1.25 | Target Price | $5.11 |
| Payout | - | Debt/Eq | - | Earnings | 2026/11/10 | SMA50 | -5.25% ($1.58) | Rel Volume | 1.2 | Prev Close | $1.52 |
| Employees | 65 | LT Debt/Eq | - | EPS/Sales Surpr. | 3.7% -15.45% | SMA200 | -11.9% ($1.7) | Avg Volume(3M) | 0.14M | Price | $1.5 |
| IPO | 2021/4/6 | Option/Short | No/Yes | Trades | 628 | Volume | 167,260 | Change | -1.32% |
🔬 This is a medical device company that diagnoses wounds using AI. Its flagship product, DeepView, combines multispectral imaging with AI to predict the healing status of burns and diabetic foot ulcers. The company has secured a contract worth up to $150 million from the U.S. government (BARDA) and is headquartered in Dallas, Texas.
Over the past 1 year, on the lower side
49% below its 1-year high.
Traded about as much as usual. That is 120% of its average volume.
Next earnings report: November 10
6 days to go.
MDAI has weak earning power
Of every $100 in sales, $79.95 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -60.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $318. Peers typically go for $145.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -84.6%. The S&P 500 did +62% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 12.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #97 of 140 in the industry
Based on market cap of $48M.
SRTS#93 Sensus Healthcare Inc $54M PER - 
COCH#94 Envoy Medical Inc $51M PER - 
SNWV#95 Sanuwave Health Inc $51M PER 24.7 
MYO#96 Myomo Inc $51M PER - MDAI#97 Spectral AI Inc $48M PER - 
FAQ
What kind of company is MDAI?
MDAI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of MDAI?
The market cap of MDAI is approximately $48M, ranking 4,855 within its sector.
What is the 52-week high and low for MDAI?
MDAI has recorded a 52-week high of $2.97 and a low of $1.18.
